Why Is OSCAR HEALTH INC A (OSCR) Stock Up Today?

Why OSCR stock is up today

Oscar Health Inc A stock rose 7.45% to $30.45 in morning trading, driven by a combination of positive coverage and broader market dynamics. The stock opened at $28.31 and climbed steadily throughout the session, reaching an intraday high of $30.59. The move comes amid a backdrop of recent analyst activity and a scheduled investor event.

What Happened

Oscar Health announced it will host its 2026 Investor Day, a key event for investors seeking insight into the company's strategic direction and performance. The news appears to have spurred renewed interest in the stock, which is currently trading near its 52-week high of $33.10. The company reported a revenue increase of 31.9% in the trailing twelve months, but remains unprofitable with an EPS of -0.15 and a net margin of -0.3%. Despite this, the stock's beta of 2.34 indicates it is more volatile than the broader market, making it sensitive to shifts in investor sentiment.

Recent analyst activity has also contributed to the stock's momentum. Barclays upgraded Oscar Health to Overweight and raised its price target to $35. This follows a period of elevated insider selling, with CEO Mark T. Bertolini and Director Mario Schlosser each selling shares in recent weeks. The cumulative insider sales over the last 90 days amount to $106.6 million, with no insider purchases recorded.

What The Data Shows

The stock is trading at a market cap of $8.5 billion and has seen a volume of 2.2 million shares so far in the session, which is 0.3 times the 3-month daily average. The session has shown a strong upward trend, with the stock recovering from a low of $27.65 early in the morning to close near its high. While there has been no unusual options activity or significant social media chatter reported, the stock's recent performance has drawn attention from financial analysts and investors.

What To Watch

Oscar Health is scheduled to report first-quarter earnings in the coming months. Investors will be watching for details on the company's financial performance and strategic initiatives ahead of the 2026 Investor Day. Coverage breadth and analyst commentary will also be key factors to monitor as the stock continues to trend upward.